EC Number | Activating Compound | Comment | Organism | Structure |
---|---|---|---|---|
1.1.1.149 | additional information | human chorionic gonadotropin induces expression of AKR1C23 | Equus caballus |
EC Number | Cloned (Comment) | Organism |
---|---|---|
1.1.1.149 | DNA and amino acid sequence determination and analysis, expression analysis of AKR1C23 in preovulatory follicles, overexpression in HEK-293 cells | Equus caballus |
EC Number | KM Value [mM] | KM Value Maximum [mM] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|---|
1.1.1.149 | 0.003 | 0.012 | 17alpha-hydroxyprogesterone | - |
Equus caballus |
EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
1.1.1.149 | 17alpha-hydroxyprogesterone + NAD(P)H | Equus caballus | the aldo-keto reductase, AKR1C23, also shows 20alpha-hydroxysteroid dehydrogenase activity in vivo, enzyme regulation in preovulatory follicles and corpora lutea, overview | 17alpha,20alpha-dihydroxypregn-4-en-3-one + NAD(P)+ | - |
r |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
1.1.1.149 | Equus caballus | Q1XAA8 | - |
- |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
1.1.1.149 | adrenal gland | very low expression rate of AKR1C23 | Equus caballus | - |
1.1.1.149 | brain | low expression rate of AKR1C23 | Equus caballus | - |
1.1.1.149 | granulosa cell | - |
Equus caballus | - |
1.1.1.149 | heart | moderate expression rate of AKR1C23 | Equus caballus | - |
1.1.1.149 | kidney | moderate expression rate of AKR1C23 | Equus caballus | - |
1.1.1.149 | liver | moderate expression rate of AKR1C23 | Equus caballus | - |
1.1.1.149 | lung | moderate expression rate of AKR1C23 | Equus caballus | - |
1.1.1.149 | ovarian follicle | preovulatory, very high expression rate, expression analysis of AKR1C23, activity during follicular luteinization, overview | Equus caballus | - |
1.1.1.149 | skeletal muscle | moderate expression rate of AKR1C23 | Equus caballus | - |
1.1.1.149 | skin | very low expression rate of AKR1C23 | Equus caballus | - |
1.1.1.149 | spleen | very low expression rate of AKR1C23 | Equus caballus | - |
1.1.1.149 | stomach | low expression rate of AKR1C23 | Equus caballus | - |
1.1.1.149 | testis | very high expression rate of AKR1C23 | Equus caballus | - |
1.1.1.149 | thymus | very low expression rate of AKR1C23 | Equus caballus | - |
1.1.1.149 | uterus | low expression rate of AKR1C23 | Equus caballus | - |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
1.1.1.149 | 17alpha-hydroxyprogesterone + NAD(P)H | - |
Equus caballus | 17alpha,20alpha-dihydroxypregn-4-en-3-one + NAD(P)+ | - |
r | |
1.1.1.149 | 17alpha-hydroxyprogesterone + NAD(P)H | the aldo-keto reductase, AKR1C23, also shows 20alpha-hydroxysteroid dehydrogenase activity in vivo, enzyme regulation in preovulatory follicles and corpora lutea, overview | Equus caballus | 17alpha,20alpha-dihydroxypregn-4-en-3-one + NAD(P)+ | - |
r |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
1.1.1.149 | AKR1C23 | - |
Equus caballus |
EC Number | Cofactor | Comment | Organism | Structure |
---|---|---|---|---|
1.1.1.149 | NAD(P)+ | - |
Equus caballus | |
1.1.1.149 | NAD(P)H | - |
Equus caballus |